Abstract

Plants are known to have many secondary metabolites and phytochemical compounds which are highly explored at biochemical and molecular genetics level and exploited enormously in the human health care sector. However, there are other less explored small molecular weight proteins, which inhibit proteases/proteinases. Plants are good sources of protease inhibitors (PIs) which protect them against diseases, insects, pests, and herbivores. In the past, proteinaceous PIs were considered primarily as protein-degrading enzymes. Nevertheless, this view has significantly changed and PIs are now treated as very important signaling molecules in many biological activities such as inflammation, apoptosis, blood clotting and hormone processing. In recent years, PIs have been examined extensively as therapeutic agents, primarily to deal with various human cancers. Interestingly, many plant-based PIs are also found to be effective against cardiovascular diseases, osteoporosis, inflammatory diseases and neurological disorders. Several plant PIs are under further evaluation in in vitro clinical trials. Among all types of PIs, Bowman-Birk inhibitors (BBI) have been studied extensively in the treatment of many diseases, especially in the field of cancer prevention. So far, crops such as beans, potatoes, barley, squash, millet, wheat, buckwheat, groundnut, chickpea, pigeonpea, corn, and pineapple have been identified as good sources of PIs. The PI content of such foods has a significant influence on human health disorders, particularly in the regions where people mostly depend on these kind of foods. These natural PIs vary in concentration, protease specificity, heat stability, and sometimes several PIs may be present in the same species or tissue. However, it is important to carry out individual studies to identify the potential effects of each PI on human health. PIs in plants make them incredible sources to determine novel PIs with specific pharmacological and therapeutic effects due to their peculiarity and superabundance.

Highlights

  • Protease inhibitors (PIs) are well known as one of the prime candidates to have numerous applications in biotechnology and medicine

  • Protease inhibitor concentrates extracted from Chickpea seeds which enriched in Birk inhibitors (BBI)-type protease inhibitors (PIs) exhibited inhibitory activity against chymotrypsin (Magee et al, 2012)

  • The mice that were treated with heat-inactivated FBPI showed similar tumor multiplicity to the BP-treated group, indicating that inhibitory capacity. These findings indicated the ability of FBPIs as effective chemo-protectors against gastric cancer in animals and, possibly, in humans as well

Read more

Summary

Introduction

Protease inhibitors (PIs) are well known as one of the prime candidates to have numerous applications in biotechnology and medicine. Protease inhibitor concentrates extracted from Chickpea seeds which enriched in BBI-type PIs exhibited inhibitory activity against chymotrypsin (Magee et al, 2012).

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call